Kishimoto, Junji

RELIABILIGY AND VALIDITY OF THE JAPANESE-LANGUAGE VERSION OF THE IMPACT OF EVENT SCALE-REVISED (IES-R-J): FOUR STUDIES OF DIFFERENT TRAUMATIC EVENTS

ASUKAI, N., KATO, H., KAWAMURA, N., KIM, Y., YAMAMOTO, K., KISHIMOTO, J., MIYAKE, Y., & NISHIZONO-MAHER, A. (2002) · The Journal of Nervous and Mental Disease

Posttraumatic Stress Disorder ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 679

Blood biomarkers of Hikikomori, a severe social withdrawal syndrome

Hayakawa, K., Kato, T. A., Watabe, M., Teo, A. R., Horikawa, H., Kuwano, N., Shimokawa, N., Sato-Kasai, M., Kubo, H., Ohgidani, M., et al. (2018) · Scientific Reports

Youth Substance Use and School AttendancePsychosomatic Disorders and Their Treatments

Cited by 69

Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study

Kuwano, N., Kato, T. A., Setoyama, D., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Kishimoto, J., et al. (2018) · Journal of Affective Disorders

Tryptophan and brain disordersTreatment of Major Depression

Cited by 69

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial

Shiraishi, Y., Kishimoto, J., Sugawara, S., Mizutani, H., Daga, H., Azuma, K., Matsumoto, H., Hataji, O., Nishino, K., Mori, M., et al. (2024) · JAMA Oncology

Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers

Cited by 54

JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

Oku, S., Takenaka, K., Kuriyama, T., Shide, K., Kumano, T., Kikushige, Y., Urata, S., Yamauchi, T., Iwamoto, C., Shimoda, H. K., et al. (2010) · British Journal of Haematology

Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and Treatments

Cited by 51

Development of 5-day hikikomori intervention program for family members: A single-arm pilot trial

Kubo, H., Urata, H., Sakai, M., Nonaka, S., Saito, K., Tateno, M., Kobara, K., Hashimoto, N., Fujisawa, D., Suzuki, Y., et al. (2020) · Heliyon

Youth Substance Use and School AttendanceFamily Caregiving in Mental Illness

Cited by 46

Randomised Phase II Study of Panitumumab plus Irinotecan versus Cetuximab plus Irinotecan in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Refractory to Fluoropyrimidine, Irinotecan and Oxaliplatin (WJOG 6510G)

Sakai, D., Taniguchi, H., Sugimoto, N., Tamura, T., Nishina, T., Hara, H., Esaki, T., Denda, T., Sakamoto, T., Okuda, H., et al. (2020) · European Journal of Cancer

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 23

Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1

Tanaka, Y., Daida, H., Imai, Y., Miyauchi, K., Sato, Y., Hiwatari, M., Kitagawa, A., Kishimoto, J., Yamazaki, T., & Kawamori, R. (2009) · Hypertension Research

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 16